Firazyr 30 mg Injektionslösung সুইজারল্যান্ড - জার্মান - Swissmedic (Swiss Agency for Therapeutic Products)

firazyr 30 mg injektionslösung

takeda pharma ag - icatibantum - injektionslösung - icatibantum 10 mg ut icatibanti acetas, natrii chloridum, natrii hydroxidum, acidum aceticum glaciale, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - behandlung von angioödem (treatment of angioedema) - synthetika

Icatibant Xiromed 30 mg 10 mg/ml, Injektionslösung in einer Fertigspritze সুইজারল্যান্ড - জার্মান - Swissmedic (Swiss Agency for Therapeutic Products)

icatibant xiromed 30 mg 10 mg/ml, injektionslösung in einer fertigspritze

xiromed sa - icatibantum - 10 mg/ml, injektionslösung in einer fertigspritze - icatibantum 30 mg ut icatibanti acetas, natrii chloridum, acidum aceticum glaciale, natrii hydroxidum, aqua ad iniectabile, q.s. ad solutionem pro 3 ml corresp. natrium 9.9 mg. - behandlung von angioödem (treatment of angioedema) - synthetika

Icatibant Accord ইউরোপীয় ইউনিয়ন - জার্মান - EMA (European Medicines Agency)

icatibant accord

accord healthcare s.l.u. - icatibant acetate - angioödeme, erblich - other hematological agents - icatibant accord is indicated for symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults, adolescents and children aged 2 years and older, with c1 esterase inhibitor deficiency.